Prevalence data regarding this disorder remains incomplete, however it is estimated that anywhere between 1 in 1,000,000 to 3 in 1,000,000 individuals will be afflicted with this disorder (based upon observed cases in a population), but once again this is only an estimate as the disease is so rare it is difficult to statistically and accurately ascertain.
Pantothenate kinase-associated neurodegeneration
Cerebral creatine deficiency
Neuronal ceroid lipofuscinosis
N-Acetylglutamate synthase deficiency
Autoimmune GFAP astrocytopathy
Dopamine beta hydroxylase deficiency
Glycogen storage disease
Lysosomal storage disease